Snapshot · TOPIX 500 · generated 2026-11-11 21:48 UTC

4503.T — Astellas Pharma Inc.

EXPENSIVE (MOS -82.5%) · Quality 77/100

Value Score 30 days ago: 20.7 → today 11.6

4503.T - Astellas Pharma Inc.
Data generated 2026-11-11 21:48 UTC (nightly scan, universe: TOPIX 500).
Price: 2634.5 USD
Intrinsic value: 1443.87 USD
Margin of safety: -82.5%
Implied growth (reverse DCF): +17.4% (model assumes +6.3%)
Valuation: EXPENSIVE
Value Score: 11.6
Quality: 77/100
Moat score: 71.2 (erosion: none)
EXPENSIVE (MOS -82.5%) - Quality 77/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/4503.T
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

2634.5

Intrinsic value

1443.87

Margin of safety

-82.5%

Implied growth (reverse DCF)

+17.4%

model assumes +6.3%

Value Score

11.6

Quality

Psychology

-25.7

Discovery

13.1

price/volume attention only

Moat score

71.2

erosion: none

Value Score: bottom 15% of TOPIX 500 · Quality: top 6%

Dividend: 79/share (TTM) · yield 3.0% · payout 39%

Open the interactive Deep Dive for 4503.T →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/4503.T - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is 4503.T undervalued?

As of 2026-11-11, 4503.T trades at 2634.5 against a computed intrinsic value of 1443.87 (-82.5% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Astellas Pharma Inc.'s Value Score?

Astellas Pharma Inc.'s Value Score is 11.6 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does 4503.T pay a dividend?

Yes - 4503.T's trailing twelve-month dividend is 79/share, a yield of 3.0% at the current price (as of 2026-11-11).